Medication
Lidocaine Injection BP
DIN 02462451 · Auro Pharma Inc
What it is
- Active ingredients
- Form and route
- Solution · Block/Infiltration
- Schedule
- ETHICAL
- Authorised since
- 2021-06-09
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Xylocaine Jelly 2%
- Xylocard
- Xylocaine 2%
- Xylocaine Jelly 2%
- Lidocaine Hydrochloride Injection Usp
- Lidocaine Hydrochloride Injection Usp
- Lidodan Viscous 2%
- Lidodan Jelly 2%
- Xylocaine 2%
- Cathejell
- Lidocaine Hydrochloride Injection Usp
- Lidocaine Hydrochloride Injection Usp
- Jelido
- Lidocaine Hydrochloride Injection
- Lidocaine Hydrochloride Injection
- Lidocaine Injection BP
- Lidocaine Hydrochloride Injection
- Lidocaine Hydrochloride Injection Usp
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Ontario Drug Benefit coverage
As of 31 July 2026This medication is not listed on the Ontario Drug Benefit formulary.
Not on the formulary is not the same as not covered. Private and workplace insurance, federal programs such as Non-Insured Health Benefits and Veterans Affairs, and every other province’s public plan are all outside what this page shows — Ontario is the only province RxMonitor holds coverage data for. Ontario may also fund a product that is not on the formulary through the Exceptional Access Program.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N01BB02
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N01BB02, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026No Health Canada recall has been matched to this product.
This is not a statement that no recall exists for this medication. Health Canada’s recalls data carries no DIN and no company name, so notices are matched on wording alone — and 1,437 of the 2,306 drug notices in the feed could not be matched to any product at all. Check Health Canada’s own search before concluding anything.
Search Health Canada recalls for Lidocaine Injection BP →
How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.